Bionoid Pharma, Inc. (BINP)
Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic
$0.03
Market Cap
$1.62M
PE (TTM)
-6.00
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-4.66
Day Range
$0.03 – $0.03
52-wk Range
$0.02 – $0.45
Avg Volume
N/A
Volume
1.00K
Bionoid Pharma, Inc. (BINP) is a publicly traded company in the Healthcare sector. Latest price: $0.03. Market cap $1.62M. Trailing PE -6.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About Bionoid Pharma, Inc.
Bionoid Pharma, Inc. functions as a medical technology enterprise. This company concentrates on the creation and commercialization of advanced medical instruments and solutions, primarily targeting the orthopedic and pain management industries. Founded on October 20, 1997, its corporate headquarters are situated in Beverly Hills, California.
Valuation
| P/E (TTM) | -6.00× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -19.28× |
| PEG | 0.05× |
| P/FCF (TTM) | 7042.77× |
| EV / EBITDA | 3.19× |
| EV / Sales | 0.00× |
| Earnings Yield | -19.57% |
| Free Cash Flow Yield | 0.01% |
Fundamentals
| Enterprise Value | $1.77M |
|---|---|
| Net Income (TTM) | -$317.00K |
| Free Cash Flow (TTM) | $1.88K |
| Net Debt | $152.19K |
| Working Capital | -$102.67K |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 395.59% |
| Return on Invested Capital | -390.40% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap